"We're not data points, we're human beings."

Cindy Beasley was both honored and intrigued when she received the invitation to attend the inaugural Pulmonary Clinical Trials Workshop (PCT). As a representative of The LAM Foundation and a patient living with a rare lung disease, she wondered what role patients would truly play in a meeting centered on clinical trials.

She quickly found her answer.

"I was very honored and honestly very curious. The more I learned about PCT and its commitment to meaningfully integrate the patient voice, the more excited I became."

Too often, Cindy believes, patients are invited into scientific conversations only after the agenda has already been set.

"At first I was a little skeptical because patients can sometimes be seen as an afterthought. But PCT was really intentional in how they incorporated us—not just into the program, but into the philosophy of the meeting."

Representing the LAM Foundation carried special meaning.

LAM is a rare lung disease that primarily affects women, and because of its rarity, many patients spend years searching for answers.

"When you have a rare lung disease, it is often invisible to others. We struggle every day, even though people don't always see it. To represent The LAM Foundation and give visibility to a community that has always put patient voice at the center of what it does was a real honor."

For Cindy, patient participation is about much more than sharing an emotional story.

"The impact of science and clinical trials is felt most by patients."

She believes researchers and patients each bring expertise that the other cannot.

"What may be important to a researcher may not have any real-world impact on a patient. Bringing those perspectives together creates better understanding—and ultimately better research."

One conversation during a coffee break particularly stayed with her. A researcher from Germany described the challenges of meaningfully integrating patient perspectives into research and wished there were a way to better access those voices.

That exchange sparked a deeper reflection.

"It made me realize we're still in an evolutionary phase of patient engagement."

Cindy left PCT asking an important question:

"Is all researchers want from us our stories—or is there more that patients can contribute?"

She believes the next step is to move beyond simply inviting patients into the room and toward defining what meaningful patient involvement actually looks like.

"We're not data points. We're human beings with struggles, priorities, and experiences. The work researchers do has a direct impact on our lives."

For patients considering participating in future scientific meetings, Cindy encourages them to look beyond the invitation itself.

"Ask whether the patient voice has been intentionally built into the conference. Is there a meaningful role? Will your perspective truly be heard?"

At PCT, she felt the answer was yes.

"It was meaningful to interact with researchers, clinicians, and data scientists who genuinely wanted to hear my voice. That doesn't always happen."

In one word, Cindy described her experience at PCT as:

"Inspirational."

The meeting reinforced her belief that the future of clinical research depends on genuine collaboration—not only between scientists, clinicians, regulators, and industry, but with the people whose lives are directly shaped by every discovery.

"When we work together, we all succeed."